UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000037044 |
|---|---|
| Receipt number | R000040894 |
| Scientific Title | Investigation of novel cell adhesion molecule ligands to elucidate the antiinflammatory mechanism |
| Date of disclosure of the study information | 2019/06/12 |
| Last modified on | 2023/06/16 15:40:36 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Investigation of novel cell adhesion molecule ligands to elucidate the antiinflammatory mechanism
Acronym
Investigation of novel cell adhesion molecule ligands to elucidate the antiinflammatory mechanism
Scientific Title
Investigation of novel cell adhesion molecule ligands to elucidate the antiinflammatory mechanism
Scientific Title:Acronym
Investigation of novel cell adhesion molecule ligands to elucidate the antiinflammatory mechanism
Region
| Japan |
Condition
Condition
sepsis
Classification by specialty
| Emergency medicine | Intensive care medicine | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Analyze the binding between anticoagulants and human leukocytes.
Basic objectives2
Others
Basic objectives -Others
Identification of novel integrin ligands
Trial characteristics_1
Exploratory
Trial characteristics_2
Explanatory
Developmental phase
Not applicable
Assessment
Primary outcomes
Discovery of leukocyte integrins and novel ligands
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Diagnosis
Type of intervention
| Other |
Interventions/Control_1
Blood is collected to identify the ligand.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1) Age is over 20 years old
2) Informed consent must be obtained to participate in this research.
Key exclusion criteria
nothing
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | Eiji |
| Middle name | |
| Last name | Kawamoto |
Organization
Mie University Hospital
Division name
Disaster and Emergency medicine.
Zip code
514-8507
Address
Edobashi 2-174, Tsu city
TEL
059-232-1111
a-2kawamoto@clin.medic.mie-u.ac.jp
Public contact
Name of contact person
| 1st name | Eiji |
| Middle name | |
| Last name | Kawamoto |
Organization
Mie University Hospital
Division name
Disaster and Emergency medicine.
Zip code
514-8507
Address
Edobashi 2-174, Tsu city
TEL
0592321111
Homepage URL
a-2kawamoto@clin.medic.mie-u.ac.jp
Sponsor or person
Institute
Mie University Hospital
Disaster and Emergency medicine.
Institute
Department
Personal name
Funding Source
Organization
Mie University Hospital
Disaster and Emergency medicine.
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Mie University Hospital Disaster and Emergency medicine.
Address
Edobashi 2-174, Tsu city
Tel
0592321111
a-2kawamoto@clin.medic.mie-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 06 | Month | 12 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2016 | Year | 08 | Month | 02 | Day |
Date of IRB
| 2016 | Year | 08 | Month | 03 | Day |
Anticipated trial start date
| 2017 | Year | 08 | Month | 02 | Day |
Last follow-up date
| 2024 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2019 | Year | 06 | Month | 12 | Day |
Last modified on
| 2023 | Year | 06 | Month | 16 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040894
